Manufacturing, Packaging & Detailing Market Research Reports & Industry Analysis
Current Good Manufacturing Practices (cGMPs) refers to the regulations enforced by the FDA. The cGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities.
Adherence to the cGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. This includes establishing strong quality management systems, obtaining appropriate quality raw materials, establishing robust operating procedures, detecting and investigating product quality deviations, and maintaining reliable testing laboratories. This formal system of controls at a pharmaceutical company, if adequately put into practice, helps to prevent instances of contamination, mix-ups, deviations, failures, and errors. This assures that drug products meet their quality standards.
The cGMP requirements were established to be flexible in order to allow each manufacturer to decide individually how to best implement the necessary controls by using scientifically sound design, processing methods, and testing procedures. The flexibility in these regulations allows companies to use modern technologies and innovative approaches to achieve higher quality through continual improvement.
- Use of RFID in serialized unique packaging numbering to authenticate and check for recall/expiry status.
- Use of X-ray and metal detection systems to detect glass, stone, bone, rubber and other contaminants
- Use of checkweighers and sorters
- Use of baggers capable of handling, opening and sealing bags manufactured from specialist sterile films and papers.
- Use of quality control labeling systems
It is important to note that cGMPs are minimum requirements. Many pharmaceutical manufacturers are already implementing comprehensive, modern quality systems and risk management approaches that exceed these minimum standards. This is important because a consumer cannot detect through smell, touch, or sight if a drug product is safe or if it will work.
Manufacturing, Packaging & Detailing Industry Research & Market Reports
-
Global Intravenous Iron Drugs Databank Market Report
... 2023 to 2031. Ferric Carboxymaltose segment is expected to be the highest contributor to this market, with $1,459.4 Million in 2022, and is anticipated to reach $2,668.4 Million by 2031, registering a CAGR of 6.98%. ... Read More
-
Global Anti-Tumor Drugs Databank Market Report
... 2029. Chemotherapy segment is expected to be the highest contributor to this market, with $234,295.8 Million in 2020, and is anticipated to reach $496,893.9 Million by 2029, registering a CAGR of 8.76%. Hormonal Therapy segment ... Read More
-
Global Sustained Release Excipients Databank Market Report
... 2023 to 2031. Polymers segment is expected to be the highest contributor to this market, with $500.3 Million in 2022, and is anticipated to reach $897.6 Million by 2031, registering a CAGR of 6.76%. Alcohol ... Read More
-
Global Active Pharmaceutical Ingredients CDMO Databank Market Report
... 11.58% from 2021 to 2029. Highly Potent Active Pharmaceutical Ingredient (HP-API) segment is expected to be the highest contributor to this market, with $53.5 Million in 2020, and is anticipated to reach $149.2 Million by ... Read More
-
Global Pharmaceutical Filtration Databank Market Report
... 2031. Membrane filters segment is expected to be the highest contributor to this market, with $5,579.4 Million in 2022, and is anticipated to reach $12,195.3 Million by 2031, registering a CAGR of 9.13%. Cartridges & ... Read More
-
Global Anti-infective Agents Databank Market Report
... 2029. Antiviral segment is expected to be the highest contributor to this market, with $47,421.1 Million in 2020, and is anticipated to reach $93,843.3 Million by 2029, registering a CAGR of 7.93%. Antiviral and Antibacterial ... Read More
-
Global Anti-Counterfeit Databank Market Report
... & Trace segment is expected to be the highest contributor to this market, with $71,792.0 Million in 2022, and is anticipated to reach $172,567.2 Million by 2031, registering a CAGR of 10.30%. Covert segment is ... Read More
-
Global Ethanolamines Databank Market Report
... (MEA) segment is expected to be the highest contributor to this market, with $657.7 Million in 2022, and is anticipated to reach $974.3 Million by 2031, registering a CAGR of 4.50%. Monoethanolamine (MEA) and Triethanolamine ... Read More
-
Basic Pharmaceutical Product Manufacturing in Ireland - Industry Market Research Report
... products. Over the past few years, an ageing Irish population has bolstered demand for pharmaceutical products, as pharmaceutical treatments for degenerative illnesses have become more popular. Rising obesity levels and associated health conditions, such as ... Read More
-
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325400
... Top Companies Within Its Industry, and Revenue Forecasts to 2030, NAIC 325400 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Pharmaceuticals, Medicines, ... Read More
-
Global Pharmaceutical Industry Outlook, 2024
... period is 2021–2028, with 2023 as the base year and 2024–2028 as the forecast period. The geographic scope includes 5 regions: North America, Latin America (LATAM) and the Caribbean, Asia-Pacific (APAC), Europe, and the Middle ... Read More
-
Pharmaceuticals and Druggists' Merchandise Distributors (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 424210
... Within Its Industry, and Revenue Forecasts to 2030, NAIC 424210 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Pharmaceuticals and Druggists' Merchandise ... Read More
-
Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing in Italy - Industry Market Research Report
... size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares. Read More
-
Pharmaceutical Product & Preparations Manufacturing in Spain - Industry Market Research Report
... size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares. Read More
-
Medical Affairs Outsourcing Market by Services (Medical Communications, Medical Information Services, Medical Monitoring), Operational Model (Full-Service Outsourcing, Functional Outsourcing, Partial/Task-based Outsourcing), End-User - Global Forecast 2024-2030
... USD 9.78 billion in 2023 and expected to reach USD 11.16 billion in 2024, at a CAGR 14.59% to reach USD 25.39 billion by 2030 . Medical affairs is an essential function within the life ... Read More
-
Pharmaceutical Product & Preparations Manufacturing in Italy - Industry Market Research Report
... size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares. Read More
-
Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing in Spain - Industry Market Research Report
... size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares. Read More
-
Pharmaceutical Product & Preparations Manufacturing in France - Industry Market Research Report
... size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares. Read More
-
Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing in France - Industry Market Research Report
... size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares. Read More
-
Chitosan Market Size, Trends, Analysis, and Outlook By Grade (Industrial Grade, Food Grade, Pharmaceutical Grade), By Application (Water Treatment, Food & Beverages, Cosmetics, Medical & Pharmaceuticals, Agrochemicals, Others), by Country, Segment, and Companies, 2024-2032
... global Chitosan market size is poised to register 12.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Chitosan market across By Grade ... Read More
-
Regulatory Reporting and Compliance Market Size, Trends, Analysis, and Outlook By Type (Regulatory Consulting, Product Registration and Clinical Trials, Legal Representation, Regulatory Writing and Publishing, Others), By Service Provider (In-House, Out-Sourcing), By End-User (Pharmaceuticals Companies, Medical Devices Companies, Biotechnology Companies), by Country, Segment, and Companies, 2024-2032
... Medical Devices Companies, Biotechnology Companies), by Country, Segment, and Companies, 2024-2032 The global Regulatory Reporting and Compliance market size is poised to register 13.6% growth from 2024 to 2032, presenting significant growth prospects for companies ... Read More
-
Organoids Market Size, Trends, Analysis, and Outlook By Product (Intestine, Liver, Stomach, Pancrease, Others), By Application (Drug Discovery and Personalized Medicine, Drug Toxicity and Efficacy Testing, Regenerative Medicine, Developmental Biology, Others), By End-User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Research Institutes), by Country, Segment, and Companies, 2024-2032
... Biotechnology Companies, Contract Research Organizations, Research Institutes), by Country, Segment, and Companies, 2024-2032 The global Organoids market size is poised to register 15.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating ... Read More
-
Tangential Flow Filtration Market Size, Trends, Analysis, and Outlook By Product (Single-use, Reusable, Membrane Filters, Filtration Accessories), By Technology (Ultrafiltration, Microfiltration, Nanofiltration, Others), By Application (Protein Purification, Vaccine and Viral Vectors, Antibody Purification, Raw Material Filtration, Others), By End-User (Pharmaceutical &Biotechnology Companies, Contract Research Organizations& Contract Manufacturing Organizations, Research Laboratories), by Country, Segment, and Companies, 2024-2032
... Filtration, Others), By End-User (Pharmaceutical &Biotechnology Companies, Contract Research Organizations& Contract Manufacturing Organizations, Research Laboratories), by Country, Segment, and Companies, 2024-2032 The global Tangential Flow Filtration market size is poised to register 13.2% growth from ... Read More
-
Preclinical CRO Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... of the COVID-19 pandemic garnered preclinical studies for pharmaceutical products such as vaccines, drugs, and other medical products. Thus, several laboratories and companies were engaged in conducting clinical trials for effective vaccines and drugs for ... Read More
-
Pharmaceutical Drug Delivery Global Market Opportunities And Strategies To 2033
... Musculoskeletal Disorders; Metabolic Disorders3) By End User: Hospitals; Home Care Settings; Ambulatory Surgery Centers/ClinicsCovering: Pfizer Inc.; AbbVie Inc; Johnson & Johnson; Merck & Co., Inc.; Sanofi Pharmaceutical Drug Delivery Global Market Opportunities And Strategies To ... Read More